Literature DB >> 10686563

Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder.

C L Barr1, K G Wigg, J Wu, C Zai, S Bloom, R Tannock, W Roberts, M Malone, R Schachar, J L Kennedy.   

Abstract

Data from animal studies suggest that the dopamine D3 receptor gene may have a role in locomotion and behavioral regulation. Therefore, this gene has been suggested as a candidate for attention-deficit hyperactivity disorder (ADHD). The dopamine D3 receptor gene (DRD3) has two common polymorphisms, one in exon I that changes a Serine to Glycine (Ser9Gly) and alters the recognition site for the restriction enzyme MscI [Lannfelt et al., 1992]. The other common polymorphism is located in intron 5 and results in the change of a restriction site for MspI [Griffon et al., 1996]. We investigated the possibility of linkage of the dopamine D3 receptor gene in 100 small, nuclear families consisting of a proband with ADHD, their parents, and affected siblings. We examined the transmission of the alleles of each of these polymorphisms and the haplotypes of both polymorphisms using the transmission disequilibrium test [Spielman et al., 1993]. We did not observe biased transmission of the alleles at either polymorphism or any haplotype. Our findings using this particular sample do not support the role of the dopamine D3 gene in ADHD. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:114-117, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686563

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Two quantitative trait loci for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains.

Authors:  Tracey L Petryshen; Andrew Kirby; Ronald P Hammer; Shaun Purcell; Sinead B O'Leary; Jonathan B Singer; Annie E Hill; Joseph H Nadeau; Mark J Daly; Pamela Sklar
Journal:  Genetics       Date:  2005-07-05       Impact factor: 4.562

2.  Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C.

Authors:  C L Barr; K Wigg; G Zai; W Roberts; M Malone; R Schachar; R Tannock; J L Kennedy
Journal:  Mol Psychiatry       Date:  2001-05       Impact factor: 15.992

3.  D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.

Authors:  Xueliang Fan; Ming Xu; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2009-10-22       Impact factor: 5.996

Review 4.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

5.  DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study.

Authors:  Weam Fageera; Sarojini M Sengupta; Aurelie Labbe; Natalie Grizenko; Ridha Joober
Journal:  Neuromolecular Med       Date:  2018-07-26       Impact factor: 3.843

Review 6.  Dopamine genes and attention-deficit hyperactivity disorder: a review.

Authors:  Salvatore DiMaio; Nathalie Grizenko; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 7.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

Review 8.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

9.  Multivariate genomewide linkage scan of neurocognitive traits and ADHD symptoms: suggestive linkage to 3q13.

Authors:  Alysa E Doyle; Manuel A R Ferreira; Pamela B Sklar; Jessica Lasky-Su; Carter Petty; Steven J Fusillo; Larry J Seidman; Erik G Willcutt; Jordan W Smoller; Shaun Purcell; Joseph Biederman; Stephen V Faraone
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

10.  The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.

Authors:  Ting-Ting Chang; Shiou-Lan Chen; Yun-Hsuan Chang; Po-See Chen; Chun-Hsien Chu; Shih-Heng Chen; San-Yuan Huang; Nian-Sheng Tzeng; Liang-Jen Wang; Tzu-Yun Wang; Chia-Ling Li; Yi-Lun Chung; Tsai-Hsin Hsieh; I-Hui Lee; Kao-Ching Chen; Yen-Kuang Yang; Jau-Shyong Hong; Ru-Band Lu; Sheng-Yu Lee
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.